CLSN
Income statement / Annual
Last year (2024), Imunon, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Imunon, Inc.'s net income was -$18.62 B.
See Imunon, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2024 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$0.00 |
$500.00 K |
$500.00 K |
$500.00 K |
$500.00 K |
$500.00 K |
$500.00 K |
$500.00 K |
$500.00 K |
$500.00 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
| Gross Profit Ratio |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$11.64 B
|
$10.62 M
|
$11.35 M
|
$13.07 M
|
$11.87 M
|
$13.08 M
|
$14.62 M
|
$14.66 M
|
$14.97 M
|
$9.36 M
|
| General & Administrative Expenses |
$7.49 B
|
$10.89 M
|
$7.64 M
|
$8.00 M
|
$9.70 M
|
$5.89 M
|
$6.53 M
|
$6.69 M
|
$8.86 M
|
$6.55 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$7.49 B
|
$10.89 M
|
$7.64 M
|
$8.00 M
|
$9.70 M
|
$5.89 M
|
$6.53 M
|
$6.69 M
|
$8.86 M
|
$6.55 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$19.13 B
|
$21.51 M
|
$18.99 M
|
$21.07 M
|
$21.57 M
|
$18.97 M
|
$21.15 M
|
$21.35 M
|
$23.83 M
|
$15.91 M
|
| Cost And Expenses |
$0.00
|
$21.51 M
|
$18.99 M
|
$21.07 M
|
$21.57 M
|
$18.97 M
|
$21.15 M
|
$21.35 M
|
$23.83 M
|
$15.91 M
|
| Interest Income |
$0.00
|
$18.15 K
|
$66.55 K
|
$442.99 K
|
$331.78 K
|
$26.04 K
|
$31.26 K
|
$186.32 K
|
$1.02 M
|
$748.95 K
|
| Interest Expense |
$0.00
|
$569.88 K
|
$1.29 M
|
$1.39 M
|
$712.03 K
|
$91.76 K
|
$722.99 K
|
$1.36 M
|
$1.33 M
|
$915.24 K
|
| Depreciation & Amortization |
$0.00
|
$702.92 K
|
$741.52 K
|
$721.67 K
|
$356.86 K
|
$553.01 K
|
$1.02 M
|
$424.97 K
|
$369.33 K
|
$339.23 K
|
| EBITDA |
-$19.13 B |
-$20.88 M |
-$21.30 M |
-$16.55 M |
-$21.23 M |
-$19.76 M |
-$20.31 M |
-$20.68 M |
-$23.80 M |
-$7.00 M |
| EBITDA Ratio |
0
|
-41.76
|
-42.59
|
-33.11
|
-42.47
|
-39.51
|
-40.62
|
-41.36
|
-47.6
|
-13.99
|
| Operating Income Ratio |
0
|
-42.01
|
-36.97
|
-41.13
|
-42.13
|
-40.62
|
-42.66
|
-42.21
|
-48.34
|
-14.67
|
| Total Other Income/Expenses Net |
$512.20 M
|
-$570.00 K
|
-$4.84 M
|
$1.90 M
|
-$712.00 K
|
-$1.93 M
|
-$723.00 K
|
-$1.36 M
|
-$1.33 M
|
$2.56 B
|
| Income Before Tax |
-$18.62 B
|
-$22.15 M
|
-$23.33 M
|
-$18.67 M
|
-$22.30 M
|
-$20.75 M
|
-$22.05 M
|
-$22.46 M
|
-$25.49 M
|
-$8.25 M
|
| Income Before Tax Ratio |
0
|
-44.31
|
-46.66
|
-37.34
|
-44.6
|
-41.5
|
-44.11
|
-44.92
|
-50.99
|
-16.5
|
| Income Tax Expense |
$0.00
|
-$1.38 M
|
-$1.85 M
|
-$1.82 M
|
-$10.42 M
|
$91.76 K
|
$722.99 K
|
$1.36 M
|
$1.33 M
|
$915.24 K
|
| Net Income |
-$18.62 B
|
-$20.77 M
|
-$21.48 M
|
-$16.85 M
|
-$11.88 M
|
-$20.75 M
|
-$22.78 M
|
-$23.82 M
|
-$26.82 M
|
-$9.17 M
|
| Net Income Ratio |
0
|
-41.54
|
-42.97
|
-33.7
|
-23.77
|
-41.5
|
-45.55
|
-47.64
|
-53.64
|
-18.33
|
| EPS |
-1.62 |
-3.83 |
-10.08 |
-11.58 |
-10.14 |
-40.3 |
-184.27 |
-229.3 |
-304.91 |
-142.16 |
| EPS Diluted |
-1.62 |
-3.83 |
-10.08 |
-11.58 |
-10.14 |
-40.3 |
-184.27 |
-229.3 |
-304.91 |
-142.16 |
| Weighted Average Shares Out |
$11.51 M
|
$5.42 M
|
$2.13 M
|
$1.46 M
|
$1.17 M
|
$508.48 K
|
$123.61 K
|
$103.87 K
|
$87.96 K
|
$64.48 K
|
| Weighted Average Shares Out Diluted |
$11.51 M
|
$5.42 M
|
$2.13 M
|
$1.46 M
|
$1.17 M
|
$508.48 K
|
$123.61 K
|
$103.87 K
|
$87.96 K
|
$64.48 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
